Follow
Eldad David Shulman
Eldad David Shulman
Research Fellow, National Cancer Institute
Verified email at nih.gov
Title
Cited by
Cited by
Year
Cell-type-specific analysis of alternative polyadenylation using single-cell transcriptomics data
ED Shulman, R Elkon
Nucleic acids research 47 (19), 10027-10039, 2019
802019
A cell-type-specific atlas of the inner ear transcriptional response to acoustic trauma
B Milon, ED Shulman, KS So, CR Cederroth, EL Lipford, M Sperber, ...
Cell reports 36 (13), 2021
752021
Genome-wide association meta-analysis identifies 48 risk variants and highlights the role of the stria vascularis in hearing loss
N Trpchevska, MB Freidin, L Broer, BC Oosterloo, S Yao, Y Zhou, B Vona, ...
The American Journal of Human Genetics 109 (6), 1077-1091, 2022
472022
Systematic identification of functional SNPs interrupting 3’UTR polyadenylation signals
ED Shulman, R Elkon
PLoS Genetics 16 (8), e1008977, 2020
362020
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome
G Dinstag, ED Shulman, E Elis, DS Ben-Zvi, O Tirosh, E Maimon, ...
Med 4 (1), 15-30. e8, 2023
282023
Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage
J Zerbib, MR Ippolito, Y Eliezer, G De Feudis, E Reuveni, A Savir Kadmon, ...
Nature Communications 15 (1), 7772, 2024
212024
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics
DT Hoang, G Dinstag, ED Shulman, LC Hermida, DS Ben-Zvi, E Elis, ...
Nature Cancer, 1-13, 2024
152024
Prediction of DNA methylation-based tumor types from histopathology in central nervous system tumors with deep learning
DT Hoang, ED Shulman, R Turakulov, Z Abdullaev, O Singh, ...
Nature Medicine, 1-10, 2024
122024
Alternative cleavage and polyadenylation generates downstream uncapped RNA isoforms with translation potential
Y Malka, F Alkan, S Ju, PR Körner, A Pataskar, E Shulman, ...
Molecular Cell 82 (20), 3840-3855. e8, 2022
122022
Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells
MR Ippolito, J Zerbib, Y Eliezer, E Reuveni, S Viganò, G De Feudis, ...
Cancer Discovery 14 (12), 2532-2553, 2024
92024
Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations
TG Chang, Y Cao, ED Shulman, U Ben-David, AA Schäffer, E Ruppin
npj Precision Oncology 7 (1), 54, 2023
8*2023
MYC induces immunotherapy and IFNγ resistance through downregulation of JAK2
E Markovits, O Harush, EN Baruch, ED Shulman, A Debby, O Itzhaki, ...
Cancer immunology research 11 (7), 909-924, 2023
52023
Genetic mapping of developmental trajectories for complex traits and diseases
ED Shulman, R Elkon
Computational and structural biotechnology journal 19, 3458-3469, 2021
32021
Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues
N Sanghvi, C Calvo-Alcañiz, PS Rajagopal, S Scalera, V Canu, S Sinha, ...
Science Advances 10 (49), eadn0220, 2024
22024
Chromosome 7 gain compensates for chromosome 10 loss in glioma
NU Nair, AA Schäffer, EM Gertz, K Cheng, J Zerbib, AD Sahu, G Leor, ...
Cancer Research 84 (20), 3464-3477, 2024
12024
Chromosome 7 to the rescue: overcoming chromosome 10 loss in gliomas
NU Nair, AA Schaffer, ME Gertz, K Cheng, J Zerbib, AD Sahu, G Leor, ...
bioRxiv, 2024.01. 17.576103, 2024
12024
ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics.
R Aharonov, G Dinstag, E Shulman, E Elis, D Ben-Zvi, O Tirosh, ...
Journal of Clinical Oncology 40 (16_suppl), e13556-e13556, 2022
12022
The expression patterns of different cell types and their interactions in the tumor microenvironment are predictive of breast cancer patient response to neoadjuvant chemotherapy
E Ruppin, SR Dhruba, S Sahni, B Wang, D Wu, P Rajagopal, ...
2024
Abstract LB242: Prediction of patient response to neoadjuvant chemotherapy in breast cancer from their deconvolved tumor microenvironment transcriptome
SR Dhruba, S Sahni, B Wang, D Wu, Y Schmidt, E Shulman, S Sinha, ...
Cancer Research 84 (7_Supplement), LB242-LB242, 2024
2024
Why does the loss of chromosomes 10 and the gain of 7 co-occur in gliomas
NU Nair, AA Schäffer, ME Gertz, K Cheng, AD Sahu, G Leor, ED Shulman, ...
Cancer Research 84 (6_Supplement), 2263-2263, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20